SCHEMBL6152226

SCHEMBL6152226

Cc1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccc(C)cc5C)cc4)c(C(=O)c4ccccc4)[nH]3)cc2)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.48
CNR2 P34972 2/20 0.44
MET P08581 1/20 0.39
KDR P35968 1/20 0.39
CNR1 P21554 1/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
PTGER2 P43116 1/20 0.39
PIM1 P11309 2/20 0.38
ESR2 Q92731 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152705 0.83 ALDH1A1 (0.49) ALOX15CNR2MAPTALDH1A1PTGER2
SCHEMBL12424116 0.82 CNR2 (0.57) ALOX15CNR2CNR1MAPTMEN1
SCHEMBL6152201 0.79 PTGER2 (0.54) METKDRMAPTMEN1ALDH1A1
SCHEMBL2787332 0.79 SRD5A2 (0.43) MAPTMEN1ALDH1A1KMT2APTGER2
SCHEMBL23758528 0.79 MAPT (0.47) METKDRMAPTALDH1A1PTGER2
SCHEMBL6152182 0.75 MPL (0.52) MEN1KMT2ANPC1RAB9A
SCHEMBL12424113 0.75 CNR2 (0.52) CNR2CNR1MAPTMEN1ALDH1A1
Formic Acid SCHEMBL28903029 0.74 ESR2 (0.56) CNR2MAPTMEN1KMT2AESR2
SCHEMBL14305804 0.74 HSD17B1 (0.51) CNR2MAPTMEN1ALDH1A1KMT2A
SCHEMBL6153219 0.73 CTSV (0.52) MAPTMEN1ALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK ALOX15 2345/4885CNR2 1724/4885MET 4158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.